| Schedule of Reportable Segment Financial Information |
The Company identifies its operating segments for segment reporting purposes primarily on the basis of product type, production processes, distribution methods and management organizations. Reportable Segment Financial Information (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, 2026 | | EMG | | EIG | | Corporate | | Total Consolidated | | Net Sales | $ | 723,244 | | | $ | 1,321,153 | | | $ | — | | | $ | 2,044,397 | | Cost of sales (1) | 509,125 | | | 800,231 | | | — | | | 1,309,356 | | | Selling expense | 24,802 | | | 151,200 | | | — | | | 176,002 | | | Segment Operating Income | 189,317 | | | 369,722 | | | — | | | 559,039 | | | Corporate G&A | — | | | — | | | 30,846 | | | 30,846 | | | Operating Income | 189,317 | | | 369,722 | | | (30,846) | | | 528,193 | | Interest expense (2) | — | | | — | | | (30,101) | | | (30,101) | | | Other (expense) income, net | — | | | — | | | (5,720) | | | (5,720) | | | Income before Income Taxes | $ | 189,317 | | | $ | 369,722 | | | $ | (66,667) | | | $ | 492,372 | | | | | | | | | | | Depreciation | 15,732 | | | 19,417 | | | 1,655 | | | 36,804 | | | Amortization | 18,811 | | | 50,316 | | | — | | | 69,127 | | | Total depreciation and amortization | $ | 34,543 | | | $ | 69,733 | | | $ | 1,655 | | | $ | 105,931 | | | | | | | | | | Research, Development & Engineering costs (3) | $ | 22,099 | | | $ | 88,822 | | | $ | — | | | $ | 110,921 | | | | | | | | | | | Assets | $ | 5,119,728 | | | $ | 10,684,591 | | | $ | 790,394 | | | $ | 16,594,713 | | | | | | | | | | | Capital Expenditures | $ | 10,908 | | | $ | 15,675 | | | $ | 5,428 | | | $ | 32,011 | |
(1)Includes $16.2 million of acquisition-related costs. (2)Includes $10.0 million of acquisition-related financing fees. (3)Included in cost of sales. | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, 2025 | | EMG | | EIG | | Corporate | | Total Consolidated | | Net Sales | $ | 618,485 | | | $ | 1,159,571 | | | $ | — | | | $ | 1,778,056 | | | Cost of sales | 452,132 | | | 690,035 | | | — | | | 1,142,167 | | | Selling expense | 22,465 | | | 125,108 | | | — | | | 147,573 | | | Segment Operating Income | 143,888 | | | 344,428 | | | — | | | 488,316 | | | Corporate G&A | — | | | — | | | 26,690 | | | 26,690 | | | Operating Income | 143,888 | | | 344,428 | | | (26,690) | | | 461,626 | | | Interest expense | — | | | — | | | (16,857) | | | (16,857) | | | Other (expense) income, net | — | | | — | | | (2,600) | | | (2,600) | | | Income before Income Taxes | $ | 143,888 | | | $ | 344,428 | | | $ | (46,147) | | | $ | 442,169 | | | | | | | | | | | Depreciation | $ | 15,665 | | | $ | 19,130 | | | $ | 1,481 | | | $ | 36,276 | | | Amortization | 26,812 | | | 44,613 | | | — | | | 71,425 | | | Total depreciation and amortization | $ | 42,477 | | | $ | 63,743 | | | $ | 1,481 | | | $ | 107,701 | | | | | | | | | | Research, Development & Engineering costs (1) | $ | 21,032 | | | $ | 73,195 | | | $ | — | | | $ | 94,227 | | | | | | | | | | | Assets | $ | 4,847,262 | | | $ | 9,541,110 | | | $ | 878,174 | | | $ | 15,266,546 | | | | | | | | | | | Capital Expenditures | $ | 10,193 | | | $ | 11,266 | | | $ | 7,810 | | | $ | 29,269 | |
(1)Included in cost of sales. | | | | | | | | | | | | | | | | | | | | | | | | | Six Months Ended June 30, 2026 | | EMG | | EIG | | Corporate | | Total Consolidated | | Net Sales | $ | 1,387,145 | | | $ | 2,585,689 | | | $ | — | | | $ | 3,972,834 | | Cost of sales (1) | 979,217 | | | 1,541,017 | | | — | | | 2,520,234 | | | Selling expense | 47,845 | | | 301,012 | | | — | | | 348,857 | | | Segment Operating Income | 360,083 | | | 743,660 | | | — | | | 1,103,743 | | | Corporate G&A | — | | | — | | | 60,614 | | | 60,614 | | | Operating Income | 360,083 | | | 743,660 | | | (60,614) | | | 1,043,129 | | Interest expense (2) | — | | | — | | | (51,010) | | | (51,010) | | | Other (expense) income, net | — | | | — | | | (6,767) | | | (6,767) | | | Income before Income Taxes | $ | 360,083 | | | $ | 743,660 | | | $ | (118,391) | | | $ | 985,352 | | | | | | | | | | | Depreciation | $ | 31,178 | | | $ | 38,595 | | | $ | 3,292 | | | $ | 73,065 | | | Amortization | 37,214 | | | 101,142 | | | — | | | 138,356 | | | Total depreciation and amortization | $ | 68,392 | | | $ | 139,737 | | | $ | 3,292 | | | $ | 211,421 | | | | | | | | | | Research, Development & Engineering costs (3) | $ | 44,630 | | | $ | 177,867 | | | $ | — | | | $ | 222,497 | | | | | | | | | | | | | | | | | | | Capital Expenditures | $ | 20,252 | | | $ | 28,516 | | | $ | 8,711 | | | $ | 57,479 | |
(1)Includes $17.8 million of acquisition-related costs. (2)Includes $10.0 million of acquisition-related financing fees. (3)Included in cost of sales. | | | | | | | | | | | | | | | | | | | | | | | | | Six Months Ended June 30, 2025 | | EMG | | EIG | | Corporate | | Total Consolidated | | Net Sales | $ | 1,206,783 | | | $ | 2,303,244 | | | $ | — | | | $ | 3,510,027 | | | Cost of sales | 889,920 | | | 1,359,218 | | | — | | | 2,249,138 | | | Selling expense | 44,257 | | | 245,548 | | | — | | | 289,805 | | | Segment Operating Income | 272,606 | | | 698,478 | | | — | | | 971,084 | | | Corporate G&A | — | | | — | | | 54,629 | | | 54,629 | | | Operating Income | 272,606 | | | 698,478 | | | (54,629) | | | 916,455 | | | Interest expense | — | | | — | | | (35,850) | | | (35,850) | | | Other (expense) income, net | — | | | — | | | (4,214) | | | (4,214) | | | Income before Income Taxes | $ | 272,606 | | | $ | 698,478 | | | $ | (94,693) | | | $ | 876,391 | | | | | | | | | | | Depreciation | $ | 31,058 | | | $ | 37,887 | | | $ | 2,917 | | | $ | 71,862 | | | Amortization | 53,455 | | | 88,751 | | | — | | | 142,206 | | | Total depreciation and amortization | $ | 84,513 | | | $ | 126,638 | | | $ | 2,917 | | | $ | 214,068 | | | | | | | | | | Research, Development & Engineering costs (1) | $ | 42,275 | | | $ | 146,817 | | | $ | — | | | $ | 189,092 | | | | | | | | | | | | | | | | | | | Capital Expenditures | $ | 17,357 | | | $ | 21,669 | | | $ | 13,312 | | | $ | 52,338 | |
(1)Included in cost of sales.
|